Hypokalemia induces renal injury and alterations in vasoactive mediators that favor salt sensitivity.

We investigated the hypothesis that hypokalemia might induce renal injury via a mechanism that involves subtle renal injury and alterations in local vasoactive mediators that would favor sodium retention. To test this hypothesis, we conducted studies in rats with diet-induced K+ deficiency. We also determined whether rats with hypokalemic nephropathy show salt sensitivity. Twelve weeks of hypokalemia resulted in a decrease in creatinine clearance, tubulointerstitial injury with macrophage infiltration, interstitial collagen type III deposition, and an increase in osteopontin expression (a tubular marker of injury). The renal injury was greatest in the outer medulla with radiation into the cortex, suggestive of an ischemic etiology. Consistent with this hypothesis, we found an increased uptake of a hypoxia marker, pimonidazole, in the cortex. The intrarenal injury was associated with increased cortical angiontensin-converting enzyme (ACE) expression and continued cortical angiotensin II generation despite systemic suppression of the renin-angiotensin system, an increase in renal endothelin-1, a decrease in renal kallikrein, and a decrease in urinary nitrite/nitrates and prostaglandin E(2) excretion. At 12 wk, hypokalemic rats were placed on a normal-K+ diet with either high (4%)- or low (0.01%)-NaCl content. Despite correction of hypokalemia and normalization of renal function, previously hypokalemic rats showed an elevated blood pressure in response to a high-salt diet compared with normokalemic controls. Hypokalemia is associated with alterations in vasoactive mediators that favor intrarenal vasoconstriction and an ischemic pattern of renal injury. These alterations may predispose the animals to salt-sensitive hypertension that manifests despite normalization of the serum K+.

[1]  S. Kalra,et al.  Dynamic changes in hypothalamic angiotensin II levels and release in association with progesterone-induced luteinizing hormone surge. , 1993, Endocrinology.

[2]  R. Kunau,et al.  Effect of potassium deficiency on papillary plasma flow in the rat. , 1979, The American journal of physiology.

[3]  L. Wei,et al.  Expression and characterization of recombinant human angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes. , 1991, The Journal of biological chemistry.

[4]  J. C. Romero,et al.  Mechanisms Underlying Pressure‐Related Natriuresis: The Role of the Renin‐Angiotensin and Prostaglandin Systems State of the Art Lecture , 1988, Hypertension.

[5]  T. Kotchen,et al.  Effect of potassium depletion on renin release. , 1982, Kidney international.

[6]  S. Kapoor,et al.  Potassium depletion exacerbates essential hypertension. , 1991, Annals of internal medicine.

[7]  T. Slowinski,et al.  Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. , 1997, The Journal of clinical investigation.

[8]  F. Epstein,et al.  On the mechanism of the effects of potassium restriction on blood pressure and renal sodium retention. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  S. Rosen,et al.  HYPOKALEMIC NEPHROPATHY IN RAT AND MAN: A LIGHT AND ELECTRON MICROSCOPIC STUDY. , 1964, Laboratory investigation; a journal of technical methods and pathology.

[10]  A. Bohle,et al.  Morphologic aspects of low-potassium and low-sodium nephropathy. , 1983, Clinical nephrology.

[11]  L. Chao,et al.  Potassium supplement upregulates the expression of renal kallikrein and bradykinin B2 receptor in SHR. , 1999, The American journal of physiology.

[12]  J. Mehta,et al.  Increased superoxide anion generation and altered vasoreactivity in rabbits on low-potassium diet. , 1998, American journal of physiology. Heart and circulatory physiology.

[13]  R. Largo,et al.  Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. , 2001, Kidney international.

[14]  C. Vio,et al.  Long-term nitric oxide synthase inhibition in rat pregnancy reduces renal kallikrein. , 1999, Hypertension.

[15]  S. Suga,et al.  Renal injury and salt-sensitive hypertension after exposure to catecholamines. , 1999, Hypertension.

[16]  C. Figueroa,et al.  Evidence for a stimulatory effect of high potassium diet on renal kallikrein. , 1987, Kidney international.

[17]  G. Arteel,et al.  Cyclosporin A increases hypoxia and free radical production in rat kidneys: prevention by dietary glycine. , 1998, The American journal of physiology.

[18]  G. G. Krishna Hypokalemic states: current clinical issues. , 1990, Seminars in nephrology.

[19]  P. Klotman,et al.  Renal vascular induction of TGF-β2 and renin by potassium depletion , 1993 .

[20]  N. Beck,et al.  Thromboxane B2 and prostaglandin E2 in the K+-depleted rat kidney. , 1981, The American journal of physiology.

[21]  S. Linas,et al.  Mechanism of the decreased renal blood flow in the potassium-depleted conscious rat. , 1981, Kidney International.

[22]  R. Buñag,et al.  Tail‐Cuff Blood Pressure Measurement without External Preheating in Awake Rats , 1982, Hypertension.

[23]  M. Dunn,et al.  Urinary excretion of prostaglandin E2 and prostaglandin F2alpha in potassium-deficient rats. , 1978, Prostaglandins.

[24]  S. Schwartz,et al.  Salt-sensitive hypertension develops after short-term exposure to Angiotensin II. , 1999, Hypertension.

[25]  S. Schwartz,et al.  Renal and Vascular Injury Induced by Exogenous Angiotensin II Is AT1 Receptor-Dependent , 2001, Nephron.

[26]  E. Krieger,et al.  State-of-the-Art lecture: influence of exercise training on neurogenic control of blood pressure in spontaneously hypertensive rats. , 1999, Hypertension.

[27]  R. Prior,et al.  Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite. , 1995, Analytical biochemistry.

[28]  J. Mehta,et al.  Critical role of AT1 receptor expression after ischemia/reperfusion in isolated rat hearts: beneficial effect of antisense oligodeoxynucleotides directed at AT1 receptor mRNA. , 1998, Circulation research.

[29]  G. Capasso,et al.  Potassium and sodium transport along the loop of Henle: effects of altered dietary potassium intake. , 1994, Kidney international.

[30]  C. Alpers,et al.  Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. , 1994, Kidney international.

[31]  J. C. Vuletin,et al.  A Light and Electron Microscopic Study , 1976 .

[32]  M. Brezis,et al.  Chronic cyclosporine-induced nephropathy in the rat. A medullary ray and inner stripe injury. , 1990, Transplantation.

[33]  R. Johnson,et al.  Hypothesis: the role of acquired tubulointerstitial disease in the pathogenesis of salt-dependent hypertension. , 1997, Kidney international.

[34]  S. Kapoor,et al.  Increased blood pressure during potassium depletion in normotensive men. , 1989, The New England journal of medicine.

[35]  A. Maxwell,et al.  The effect of hypobaric hypoxia on misonidazole binding in normal and tumour-bearing mice. , 1989, British Journal of Cancer.

[36]  G. Arteel,et al.  Reductive metabolism of the hypoxia marker pimonidazole is regulated by oxygen tension independent of the pyridine nucleotide redox state. , 1998, European journal of biochemistry.

[37]  M. Mitchell,et al.  Hypokalaemia stimulates prostacyclin synthesis in the rat. , 1983, Clinical science.

[38]  F. Epstein Oxygen and renal metabolism. , 1997, Kidney international.

[39]  H. Langford Potassium in hypertension. , 1983, Postgraduate medicine.

[40]  R. Stahl,et al.  Inhibition of rabbit renal prostaglandin E2 biosynthesis by chronic potassium deficiency. , 1981, The Journal of laboratory and clinical medicine.

[41]  J. Ménard,et al.  Renal proliferative and phenotypic changes in rats with two-kidney, one-clip Goldblatt hypertension. , 1994, American journal of hypertension.

[42]  Y. G. Kim,et al.  Post-cyclosporine-mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor. , 2001, American journal of physiology. Renal physiology.

[43]  O. Carretero,et al.  Immunocytochemical localization of renin and kallikrein in the rat renal cortex. , 1986, Kidney international.

[44]  V. Velarde,et al.  Localization of components of the kallikrein-kinin system in the kidney: relation to renal function. State of the art lecture. , 1992, Hypertension.

[45]  G. Arteel,et al.  Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. , 1995, British Journal of Cancer.

[46]  S. E. Thomas,et al.  Tubulointerstitial disease in aging: evidence for underlying peritubular capillary damage, a potential role for renal ischemia. , 1998, Journal of the American Society of Nephrology : JASN.

[47]  N. Glorioso,et al.  Kallikrein-kinin system and blood pressure sensitivity to salt. , 1997, Hypertension.

[48]  C. Baylis,et al.  Acute changes in urinary excretion of nitrite + nitrate do not necessarily predict renal vascular NO production. , 1995, Kidney international.

[49]  C. Baylis,et al.  Chronic nitric oxide inhibition model six years on. , 1998, Hypertension.

[50]  T. Hostetter,et al.  Hypokalemic nephropathy in the rat. Role of ammonia in chronic tubular injury. , 1987, The Journal of clinical investigation.

[51]  O. Carretero,et al.  Effect of high salt intake in mutant mice lacking bradykinin-B2 receptors. , 1997, Hypertension.

[52]  R. Largo,et al.  Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition. , 2001, American journal of physiology. Renal physiology.